The CIP-creator GPT input yaml file

Detailed Description of CIP-Intake YAML This page explains the CIP-Intake YAML used by the MR-clinical-trial-CIP-Creator GPT to validate your inputs and generate a regulator-aligned Clinical Investigation Plan (CIP) skeleton for CH and/or EU submissions.    Download YAML Empty example.yaml file   What the YAML is for File rules & formatting Minimal valid example Full scaffold… Continue reading The CIP-creator GPT input yaml file

Competent Agencies for Medical Device Trials in EU-Memberstates

Overview in MDR Article 82 Context Interventional clinical investigations of non–CE-marked MRI and MR spectroscopy devices (e.g. novel RF coils, pulse sequences) are governed by the EU Medical Device Regulation (MDR, Regulation (EU) 2017/745). Specifically, if these trials are not undertaken to support CE-marking of the device (i.e. they are “other” clinical investigations under MDR… Continue reading Competent Agencies for Medical Device Trials in EU-Memberstates

How to apply for a CA Approval in the EU

🇪🇺 How to apply for a Competent Agency (CA) Approval in the EU for your MR-research When planning a magnetic resonance (MR) research study in the EU using non-CE-marked RF hardware or novel pulse sequences, you must obtain approval from the national Competent Authority (CA) in each country where the study will run. This CA… Continue reading How to apply for a CA Approval in the EU

General Safety & Performance Requirements — Normal and Deuterated-Glucose supplementation related documents

Introduction to Food Supplementation in Clinical Trials Regulatory Considerations for Swissmedic / [or local responsible EU-CA]  and Ethics Proposals Clinical trials involving food supplementation, such as α-D-glucose and 6,6’-d-glucose, require thorough planning and regulatory compliance due to their dual status as food substances and investigational products. While generally recognized as safe under normal dietary circumstances,… Continue reading General Safety & Performance Requirements — Normal and Deuterated-Glucose supplementation related documents

Welcome to: “Swiss ClinO-MD & EU-MDR — Investigator Initiated Trials in MR-Research”

Surviving the Compliance Inquisition - Practical Help for MR Investigators

Navigating the world of clinical trial compliance can feel like a journey through a bureaucratic labyrinth, or worse, a modern-day compliance inquisition. When I set out to write my combined Swissmedic and ethics proposals for a research study in MRI, I knew it would be challenging. But nothing prepared me for the sheer scale of… Continue reading Welcome to: “Swiss ClinO-MD & EU-MDR — Investigator Initiated Trials in MR-Research”

General Safety & Performance Requirements — 1H/2H-dual tuned RF-coil related

You need to be logged in to view this content. Please Log In. Not a Member? Join Us

Ethics proposal — The Clinical Investigation Plan (CIP)

You need to be logged in to view this content. Please Log In. Not a Member? Join Us

General Safety & Performance Requirements — Risk Analyses Overall System of Trial

Comply-or-die-in MR-science

You need to be logged in to view this content. Please Log In. Not a Member? Join Us

Research on Investigational Medical Devices in Switzerland: Legal Insights and EU-MDR Context

Switzerland’s regulatory framework for clinical investigations with medical devices, including investigational devices like experimental MR-pulse sequences and non-CE-marked RF coils, is governed by the Ordinance on Clinical Trials with Medical Devices (ClinO-MD). This aligns with the Swiss Human Research Act (HRA) and is influenced by the European Union’s Medical Device Regulation (EU-MDR) to ensure harmonized… Continue reading Research on Investigational Medical Devices in Switzerland: Legal Insights and EU-MDR Context

Ethics proposal — The Clinical Investigation Plan (CIP)

Introduction Navigating the bureaucracy behind clinical trials in Switzerland is no small feat. As a researcher preparing the SIGNATURES2023 study, I quickly found that working with both the local Cantonal Ethics Commission (CEC) and Swissmedic / EMA — two independent bodies with their own rules and regulations — requires a level of coordination and compliance that… Continue reading Ethics proposal — The Clinical Investigation Plan (CIP)